Early intervention in type 2 diabetes

The 2026 update of the American Diabetes Association-European Association for the Study of Diabetes (ADA-EASD) consensus highlights the importance of starting organ protection immediately in patients with type 2 diabetes, moving beyond a focus on blood sugar control alone.

Shift in management approach

The updated guidelines stress the need to treat type 2 diabetes earlier, aiming to protect organs before complications develop, refine treatment goals, and address previously overlooked health issues.

New therapeutic recommendations

The consensus recommends the use of SGLT2 inhibitors and/or GLP-1 agonists from the moment of diagnosis, reflecting a more proactive approach to managing the disease.

Focus on pregnancy and treatment

The guidelines also include recommendations for regulating the use of GLP-1-based treatments during pregnancy, ensuring safety for both the mother and the fetus.

Broader understanding of diabetes

Type 2 diabetes is now viewed as more than just a condition related to blood sugar levels, with a greater emphasis on overall health and long-term organ function.